ADHD Parenting Group in Vancouver, Washington
Are you feeling overwhelmed or unsure where to start after your child’s ADHD diagnosis? You’re not alone.
Group Overview:
This workshop is designed for parents and caregivers of children ages 3–17 who want guidance, resources, and a safe space to learn and ask questions.
Together, we’ll explore:
• What ADHD is and how it shows up in children
• How the ADHD brain works differently
• Treatment options and lifestyle approaches that can help
• Strategies for working with schools, teachers, and distance learning
• Practical tools for parenting and supporting your child with ADHD
You’ll leave with resources, knowledge, and encouragement to help you and your child thrive.
Participants: Parents/guardians of children and adolescents (ages 3-17) with ADHD
When: In-person on Saturdays from 1 to 2:30 p.m., starting January 10 and ending February 10, 2026
Cost: Insurance and self-pay are accepted in Washington
Facilitator:
Dr. Christopher Fraczek is a Clinical Psychologist who has been practicing since 2001. He graduated from Alliant International University, Los Angeles with a degree in Clinical Psychology.
The enrollment period for this program ended on February 10th, 2026.
If you have any questions, please call
503-233-5405
for assistance.
Participating Location
Participating Providers
Christopher Fraczek
PsyD
Additional Group Therapy In Washington
Related Blogs
Hyperfixation and Neurodivergence: Exploring Its Role in ADHD, Autism, and Beyond
Hyperfixation is intense, hard-to-break focus common in ADHD and autism. Learn what it means, how it shows up differently across conditions, and strategies to manage it.
ADHD Patch Medication: Benefits, Side Effects and What to Know, Explained by a Psychiatrist
Are ADHD patches like Daytrana and Xelstrym right for you? A psychiatrist explains how they work, their benefits, side effects, and who they may help most.
Jornay PM: The ADHD Stimulant Medication Taken at Night, Not in the Morning
Jornay PM is the first ADHD stimulant formulated to be taken at night and designed to start working upon waking up. Here is how it works, who it helps, and how it compares to other ADHD drugs.
Rejection Sensitive Dysphoria: What It Is, Is It Real, and How It’s Linked to ADHD
Rejection sensitive dysphoria (RSD) causes intense emotional pain from perceived rejection. Learn what it is, how it connects to ADHD, whether it’s a real diagnosis, and how to treat it.
Centanafadine: New ADHD Medication in 2026
Centanafadine is a new ADHD medication the FDA is reviewing right now. Learn what makes it different from stimulants, what the research shows, and who it may help.
3 Types of ADHD: What a New 2026 Study Found and What It Means for You
A 2026 study identified 3 distinct types of ADHD using brain scans. Learn what each type looks like and what it means for treatment.
